Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

about

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

Item

http://www.wikidata.org/entity/Q39423373

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

@en

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

@nl

type

Item

label

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

@en

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

@nl

prefLabel

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

@en

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

@nl

P1476

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

@en

P2093

Christopher Gomez

http://www.w3.org/2001/XMLSchema#string

Diana M Lopategui

http://www.w3.org/2001/XMLSchema#string

Nachiketh Soodana Prakash

http://www.w3.org/2001/XMLSchema#string

P2860

Botulinal neurotoxins: revival of an old killer

Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review

Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder.

A systematic review of the management of autonomic dysreflexia after spinal cord injury.

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

Clinical comparability of marketed formulations of botulinum toxin.

Reduction in Bladder-Related Autonomic Dysreflexia after OnabotulinumtoxinA Treatment in Spinal Cord Injury.

OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity.

Combination drug therapy improves compliance of the neurogenic bladder.

Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA.

P2888

s11934-017-0707-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11934-017-0707-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28689244

http://www.w3.org/2001/XMLSchema#string